10.1186/s12885-019-5687-0 - Relationship between tumor biomarkers...

This document has been corrected

Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer

10.1186/s12885-019-5687-0

Published Online: 2019-05-30

Journal: BMC Cancer•Publisher: Springer Science and Business Media LLC

Authors: Carlos H. Barrios•Edith A. Perez•Howard A. Burris•Masakazu Toi•Miguel Martin•Monika Patre•Paul Anthony Ellis•Pier Franco Conte•Sanne Lysbet de Haas•Sven Stanzel•Tadeusz Pienkowski•Wolfgang Eiermann•Xavier B. Pivot•Young-Hyuck Im

This document has been corrected

Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer

10.1186/s12885-019-5687-0

Published Online: 2019-05-30

Journal: BMC Cancer

NOW

2019-06-24•Correction

Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer

10.1186/s12885-019-5831-x

* information provided by CrossRef

2019-06-24•Correction

10.1186/s12885-019-5831-x

* information provided by CrossRef

2019-05-30•Published

2019-06-24•Correction

10.1186/s12885-019-5831-x

* information provided by CrossRef

This document has been corrected

Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer

10.1186/s12885-019-5687-0

Published Online: 2019-05-30

Journal: BMC Cancer•Publisher: Springer Science and Business Media LLC